Several professional health organizations have made statements endorsing the safety of breastfeeding for women taking medication-assisted treatment for an opioid use disorder. Yet, breastfeeding initiation rates for this population are approximately 50% lower than the general United States’ population. Furthermore, little is known about what influences the infant-feeding decisions of these women.Research aim:
This study aimed to describe what influences the infant-feeding decisions of women taking medication-assisted treatment for an opioid use disorder.Methods:
Qualitative description was used. We conducted semistructured, individual interviews with mothers (N = 8) who were receiving medication-assisted treatment during the postpartum period. We analyzed our data using thematic analysis.Results:
We identified two themes: (a) what I heard about breastfeeding, and (b) doing what I feel is best for my baby. What I heard about breastfeeding reflects the information and misinformation that women received about breastfeeding. Doing what I feel is best for my baby describes the inner conflict that the women experienced. Most of the women in this study desired to breastfeed; however, all women reported that the social stigma surrounding methadone use strongly influenced their infant-feeding decision.Conclusion:
This study sheds new light on what influences the infant-feeding decisions of women taking medication-assisted treatment and represents an initial step toward the development of targeted interventions to improve breastfeeding rates for this unique population.